Red Arrow Therapeutics closes $4.5M Seed Extension funding to advance pH-sensing nanomedicine drug delivery technologies
Amount Raised
$4.5 Million
Round Type
Seed
BostonBiotechnologyHealth CareTherapeuticsInvestors
Description
Red Arrow Therapeutics Inc., a developer of pH-sensing nanomedicine drug delivery technologies, closed a $4.5M Seed Extension round. The funding will be used to obtain key preclinical data on safety and efficacy of their lead compound, IL-12-loaded nanopolymeric micelles, and enable manufacturing initiation in collaboration with external partners.
Quick answer
Red Arrow Therapeutics raised $4.5 Million in a Seed round, dated April 23, 2024. Investors: Keio Innovation Initiative, Osaka University Venture Capital Co., Ltd., The University Of Tokyo Edge Capital Partners Co., Ltd. and Beyond Next Ventures Inc. Red Arrow Therapeutics is based in Boston, Massachusetts, United States.
- How much did Red Arrow Therapeutics raise?
- Red Arrow Therapeutics raised $4.5 Million in a Seed round on April 23, 2024.
- Who invested in Red Arrow Therapeutics?
- Keio Innovation Initiative, Osaka University Venture Capital Co., Ltd., The University Of Tokyo Edge Capital Partners Co., Ltd. and Beyond Next Ventures Inc. are named as investors in this round.
- What does Red Arrow Therapeutics do?
- Red Arrow Therapeutics, Inc. is a biotechnology company focusing on developing new technologies that can turn "cold" tumors into inflamed "hot" tumors.
- Where is Red Arrow Therapeutics based and how big is it?
- Red Arrow Therapeutics is based in Boston, Massachusetts, United States.
- Who are the decision-makers at Red Arrow Therapeutics?
- Fundz holds 1 contact at Red Arrow Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Red Arrow Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Calidi Biotherapeutics raised $5.5M on June 3, 2024.
- Summit Therapeutics raised $200M on June 3, 2024.
- Aptose Biosciences raised $4.4M (Seed) on June 3, 2024.
- Radiomer Therapeutics raised an undisclosed amount (Pre-Seed) on May 29, 2024.
- Bicycle Therapeutics raised $555M on May 28, 2024.
- Bicycle Therapeutics raised $555M (Post-IPO Equity) on May 23, 2024.
Who to call at Red Arrow Therapeutics, and when
A new round usually means Red Arrow Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Red Arrow Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Red Arrow Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Red Arrow Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Red Arrow Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Red Arrow Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.